Emergent BioSolutions Inc. (EBS)
NYSE: EBS · Real-Time Price · USD
5.49
-0.15 (-2.66%)
At close: May 15, 2025, 4:00 PM
6.05
+0.56 (10.25%)
After-hours: May 15, 2025, 7:59 PM EDT
Emergent BioSolutions Employees
Emergent BioSolutions had 900 employees as of December 31, 2024. The number of employees decreased by 700 or -43.75% compared to the previous year.
Employees
900
Change (1Y)
-700
Growth (1Y)
-43.75%
Revenue / Employee
$1,072,667
Profits / Employee
-$146,222
Market Cap
297.99M
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
EBS News
- 1 day ago - Emergent BioSolutions to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 7 days ago - Emergent BioSolutions Inc. (EBS) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 8 days ago - Emergent BioSolutions Reports First Quarter 2025 Financial Results - GlobeNewsWire
- 14 days ago - Emergent BioSolutions Reinforces Commitment to Opioid Emergency Preparedness Efforts in Canada Through Multi-Year Contract with Ontario Ministry of Health - GlobeNewsWire
- 23 days ago - Emergent BioSolutions to Report First Quarter 2025 Financial Results on May 7, 2025 - GlobeNewsWire
- 6 weeks ago - Emergent BioSolutions Announces Stock Repurchase Program - GlobeNewsWire
- 2 months ago - Emergent BioSolutions New Hire Equity Grant Under NYSE Rule 303A.08 - GlobeNewsWire
- 2 months ago - Hikma announces Health Canada approval of KLOXXADO® (naloxone HCl) Nasal Spray 8 mg - GlobeNewsWire